SAN FRANCISCO, CA, UNITED STATES, January 20, 2026 /EINPresswire.com/ -- The National Psoriasis Foundation (NPF) is ...

From treatment and skin care to following good sleep habits, here’s how to keep psoriasis symptoms from disrupting your night’s rest.

The International Federation of Psoriasis Associations (IFPA) and the WHO Foundation have signed a multi-year collaboration ...

Researchers identified multiple gene signatures linked to psoriasis severity, body weight, and immune activity. These ...

Between 20 and 30 percent of people with psoriasis eventually develop a second, more disabling problem: painful joint ...

Psoriasis is a chronic, immune-mediated condition. It typically affects the skin, but can also have implications for other organ systems, including the joints. When psoriasis affects the skin, it ...

In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis ...

An Evening of Jazz & Generosity Returns to Atlanta ATLANTA, GA, UNITED STATES, January 20, 2026 /EINPresswire.com/ ...

All weight loss interventions were associated with improved disease severity and quality of life compared with standard care in those with psoriasis.

After vunakizumab discontinuation, PASI maintenance varied; BMI, interruptions, and psoriasis duration predicted relapse.

Biologic therapies are safe for use in patients with psoriasis who also have active or recent cancer when compared with conventional therapies.

Executives from Alumis (NASDAQ:ALMS) outlined recent clinical results, upcoming regulatory milestones, and pipeline priorities during a discussion at the Guggenheim Emerging Outlook Biotech Summit ...